2022 annual financial data
Sonoma Pharmaceuticals 2022 Operating margin
Sonoma Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -46.62%.
Operating income was -5,887,000 USD and net income was -5,086,000 USD.
Operating cash flow was -4,248,000 USD.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,628,000 USD
- Operating income
- -5,887,000 USD
- Net income
- -5,086,000 USD
- Operating cash flow
- -4,248,000 USD